← Open Payments lookup

SARAH YAO: Open Payments

NPI 1205351327 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$845 in 37 payments from 14 companies in 2025. Trend: 2023 $632 · 2024 $655 · 2025 $845

Food & beverage: $845
CompanyPaymentsAmount
ABBVIE INC.8$164
Teva Pharmaceuticals USA, Inc.4$99
Takeda Pharmaceuticals U.S.A., Inc.3$84
Otsuka America Pharmaceutical, Inc.4$80
Almatica Pharma LLC3$76
E.R. Squibb & Sons, L.L.C.3$75
Neurocrine BioSciences, Inc.2$52
Janssen Pharmaceuticals, Inc2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Lundbeck LLC2$38

Products named: VRAYLAR, REXULTI, AUSTEDO XR, TRINTELLIX, LOREEV XR, COBENFY, INGREZZA, INVEGA SUSTENNA.

Industry payments across NV — which companies pay providers there.